首页|老年肺癌患者立体定向放射治疗后发生放射性肺炎的危险因素分析

老年肺癌患者立体定向放射治疗后发生放射性肺炎的危险因素分析

扫码查看
目的 分析老年肺癌患者在立体定向放射治疗(SBRT)后发生症状性放射性肺炎(SRP)的情况及其危险因素.方法 回顾性分析2014年10月-2023年6月在复旦大学附属华东医院接受SBRT治疗的150例老年非小细胞肺癌患者的临床和放疗数据,根据患者是否发生SRP分为SRP组和非SRP组.对比2组的正常肺组织生物等效剂量-体积参数(VBED10,20,30...200)、V5、V20、平均肺剂量(MLD)、肿瘤靶区(GTV)、计划靶区(PTV)及临床参数等.采用Logistic回归方法分析老年肺癌患者发生SRP的危险因素,采用ROC曲线分析相关因素对SRP发生的预测价值,并建立正常肺组织生物等效剂量-体积直方图(BEDVH).结果 SRP发生率为16%(24/150);单因素分析显示,非SRP组与SRP组肿瘤直径、PTV、放疗次数、MLD、V5、V20和VBED10-200均有统计学差异(P<0.05).多因素回归分析显示,VBED70是SRP的独立危险因素(OR=5.59,P<0.001),曲线下面积(AUC)为0.918,灵敏度为0.85,特异性为0.92,优于V5和V20(AUC值分别为0.754、0.895).VBED70最佳临界值为2.45%,不同VBED70组间SRP累积发生率有统计学差异(Log rank P<0.001).结论 对于真实世界中接受不同SBRT分割模式治疗的老年肺癌患者,与物理剂量相比,采用统一的肺生物等效剂量-体积参数可能更好地预测症状性放射性肺炎的风险.
Analysis of risk factors for radiation pneumonitis in elderly patients with lung cancer after stereotactic radiotherapy
Objective To analyze the incidence and risk factors of symptomatic radiation pneumonitis(SRP)in elderly patients with lung cancer after stereotactic radiotherapy.Methods A retrospective analysis was conducted on the clinical and radiotherapy data of 150 elderly patients with non-small cell lung cancer(NSCLC)treated by stereotactic radiotherapy in Hua-dong Hospital Affiliated to Fudan University from October 2014 to June 2023.They were divided into SRP group and non-SRP group according to whether they had SRP or not.The bioequivalent dose-volume parameters of normal lung tissue(VBED10,20,30 200),V5,V20,mean lung dose(MLD),gross tumor volume(GTV),planned target volume(PTV)and clinical parameters were compared between the two groups.Logistic regression analysis was used to identify risk factors for SRP in elderly lung cancer patients.The receiver operating characteristic(ROC)curve was used to analyze the predictive value of related factors to the occurrence of SRP.A bioequivalent dose-volume histogram(BEDVH)of normal lung tissue was drawn.Results The incidence of SRP was 16%(24/150).Univariate analysis showed that there were statistically differences in tumor diameter,PTV,radiotherapy frequency,MLD,V5,V20 and VBED10-200 between the non-SRP group and the SRP group(P<0.05).Multivariate regression analysis showed that VBED70 was an independent risk factor for SRP(OR=5.59,P<0.001),with an area under the curve(AUC)of 0.918,sensitivity of 0.85,and specificity of 0.92,which was superior to V5 and V20(AUC values of 0.754,0.895,respectively).The optimal cut-off value for VBED70 was 2.45%,and there was a statistically significant difference in the cumulative incidence of SRP among different VBED70 groups(Log rank P<0.001).Conclusion For elderly lung cancer patients receiving stereotactic radiotherapy with various fractionation schemes in the real world,the use of unified lung bioequivalent dose-volume parameters may better predict the risk of SRP than physical dose parameters.

elderlylung cancerstereotactic radiotherapysymptomatic radiation pneumonitisrisk factor

焦玉新、任艳萍、郑向鹏、林光武

展开 >

复旦大学附属华东医院放疗科,上海 200040

复旦大学附属华东医院放射科,上海 200040

老年 肺癌 立体定向放射治疗 症状性放射性肺炎 危险因素

2024

老年医学与保健
复旦大学附属华东医院

老年医学与保健

CSTPCD
影响因子:0.655
ISSN:1008-8296
年,卷(期):2024.30(6)